THC Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a THCT research report →
About the company
THC Therapeutics, Inc. is a company active in the wellness sector, primarily engaged in developing the dHydronator. This innovative device functions as a sanitizing herb dryer, specifically designed for the efficient drying and cleansing of freshly harvested cannabis, as well as a variety of other herbs, flowers, and tea leaves.
- CEO
- Scott A. Cox
- IPO
- 2017
- Employees
- 1
- HQ
- Las Vegas, NV, US
Price Chart
- Market Cap
- $34.98K
- P/E
- -0.08
- P/S
- 0.00
- P/B
- -0.01
- EV/EBITDA
- -1.68
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 12.06%
- ROIC
- 20.42%
- Revenue
- $0 · 0.00%
- Net Income
- $-387,036 · 74.52%
- EPS
- $-0.01 · 74.18%
- Op Income
- $-493,912
- FCF YoY
- 79.61%
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 7.53
- Avg Volume
- 1.45K
Get TickerSpark's AI analysis on THCT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 10, 13 | Smith Adrian J R | other | 1,000,000 |
| Nov 14, 13 | TANAKA HIRO | other | 0 |
| Sep 10, 13 | MANN JAMIE | other | 0 |
| Sep 10, 13 | MANN JAMIE | other | 6,403,726 |
| Jun 7, 10 | Ho Eden | buy | 5,000 |
| May 28, 10 | Ho Eden | buy | 19,001 |
| Mar 15, 10 | Ho Eden | other | 0 |
Our THCT coverage
Recent articles, reports, and earnings notes.
No research on THCT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate THCT report →Similar companies
Peers in the same neighborhood.